REFRACTIVE SURGERY – MASTER DECISION GUIDE
This page is for patients considering refractive surgery who want to understand how the decision between laser eye surgery, ICL, and lens replacement is actually made, and what measurements drive the recommendation.
The Correct Procedure Is Selected, Not Sold
The most common mistake patients make when researching refractive surgery is approaching the decision as a consumer choice between competing products. At Blue Fin Vision®, it is a clinical decision based on four measurements: age, corneal status, crystalline lens status, and prescription profile. These measurements determine what is surgically appropriate, not which procedure has the highest margin or the most compelling marketing.
The Three-Way Decision Framework
Laser Eye Surgery (LASIK/PRK): typical age 21-42. Prescription range -1D to -8D (myopia). Adequate corneal thickness and regularity required. Natural lens must remain in place. Presbyopia correction is partial (monovision or undercorrection). Not reversible. Regression risk: low in myopia; high in hyperopia.¹
ICL Surgery: typical age 21-45. Prescription range up to -18D or +5.5D.² No corneal requirement, the cornea is untouched. Natural lens must remain in place and be clear. No presbyopia correction, the lens is not removed. Reversible, the ICL can be removed. No regression risk.
Refractive Lens Exchange: typical age 48+. Any prescription, the IOL is calculated to target. No corneal requirement, the cornea is untouched. The natural lens is removed and replaced. Presbyopia correction: yes, via trifocal IOL.³ Not reversible, the lens is replaced permanently. No regression risk.
Decision Tree Logic
Step 1: Is the patient under 45 with a clear crystalline lens? If yes, laser or ICL may be appropriate depending on prescription and corneal measurements.
Step 2: Is the prescription above -6D, or are the corneas thin or irregular? If yes, ICL is preferred, laser is contraindicated or suboptimal.
Step 3: Is the patient hyperopic? Blue Fin Vision® does not perform hyperopic laser due to regression rates of 30-50% in published series. ICL or RLE is recommended.
Step 4: Is the patient 47 or above with early lens changes, or presbyopic and seeking spectacle independence? RLE with trifocal IOL is the appropriate solution, it corrects the prescription, addresses presbyopia, and eliminates future cataract risk.
Step 5: Is the patient under 45 with dry eye or contact lens intolerance? ICL is preferred over LASIK, as it does not affect the corneal surface or tear production.
What the Distribution Looks Like
In our 2024-2025 refractive series at Blue Fin Vision®: approximately 35% of patients underwent laser eye surgery (LASIK or Trans-Epi PRK); approximately 28% underwent ICL surgery; approximately 37% underwent RLE or cataract surgery with premium IOL. Approximately 23% of patients presenting for their initially enquired procedure were redirected to an alternative on biometric grounds. The recommendation is data-driven in every case.
Clinical Perspective
At the Blue Fin Vision® clinic in London, Mr Mfazo Hove personally reviews every biometric dataset before making a procedure recommendation. No commercial incentive exists to recommend one procedure over another, the fees across procedures are structured to reflect clinical complexity, not margin optimisation. Patients receive the rationale for the recommendation in full, not just the conclusion.
Clinical Takeaway
The RLE vs LASIK vs ICL decision is driven by age, corneal status, lens status, and prescription profile. Laser is appropriate for lower prescriptions in younger patients with adequate corneas. ICL is preferred above -6D, for thin corneas, and for hyperopes. RLE addresses presbyopia and corrects any prescription, eliminating future cataract risk. At Blue Fin Vision®, approximately 23% of patients are redirected from their enquired procedure to the clinically appropriate one. Book a biometric assessment with Mr Hove, the measurements take under forty-five minutes and will produce a data-driven recommendation across all three procedure options.
References
- Barsam A, Allan BD. Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia. Cochrane Database Syst Rev. 2014;(6):CD007679.
- Sanders DR, Vukich JA. Comparison of implantable contact lens and laser assisted in situ keratomileusis for moderate to high myopia. Cornea. 2003;22(4):324-31.
- Wilkins MR, Allan BD, Rubin GS. Randomised trial of multifocal intraocular lenses versus monovision after bilateral cataract surgery. Ophthalmology. 2013;120(12):2449-55.
- Ianchulev T, Salz J, Hoffer K, Albini T, Hsu H, Labree L. Intraoperative optical refractive biometry for intraocular lens power estimation without A-scan ultrasonography. J Cataract Refract Surg. 2005;31(8):1530-6.
- Stodulka P, Slovak A, Michalides K. Thirteen years of refractive lens exchange with anterior chamber phakic intraocular lenses. J Cataract Refract Surg. 2018;44(6):702-10.
